c-erbB-2 oncogene as a prognostic marker in breast cancer.
about
Phosphotyrosine signaling proteins that drive oncogenesis tend to be highly interconnectedBimodal gene expression patterns in breast cancerClinical significance of erbB-2 (HER-2/neu) protein.Evaluation and skeletal metastases.The polymerase chain reaction: its use in the molecular characterization and diagnosis of cancers.Prognostic significance of c-erbB-2 expression in node negative breast cancerRadioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigenRelationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases.Expression of the ERBB3 gene product in breast cancer.Critical determination of the frequency of c-erbB-2 amplification in breast cancer.Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts.Are fine-needle breast aspirates representative of the underlying solid tumour? A comparison of receptor levels, ploidy and the influence of cytokeratin gates.Significance of Her-2/neu protein over expression in Indian breast cancer patientsIndications for cytostatic therapy in metastatic breast cancer.Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone.Somatic pharmacogenomics in cancer.ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers.The silent estrogen receptor--can we make it speak?c-erbB-2 expression in FNAB smears and matched surgical specimens of breast cancer.Prognostic significance of c-erb-B2 amplification in fine-needle biopsies of breast cancer patients not operated at diagnosis.The type I growth factor receptors in human breast cancer.Molecular biology of breast carcinoma.Growth factors. Clinical implications in breast cancer.Hormonal control of growth factor receptor expression.Transgenic mouse models of breast cancer.Targeting gene transcription: a new strategy to down-regulate c-erbB-2 expression in mammary carcinomaProduction and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas.Amplification of the topoisomerase II alpha gene in a non-small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase II alpha and beta loci in normal tissue.The c-erbB-2 oncogene amplification by competitive PCR in aneuploid cell clones flow sorted from breast cancer samples.Oestrogen and epidermal growth factor down-regulate erbB-2 oncogene protein expression in breast cancer cells by different mechanisms.Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu.Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma.Significance of immunohistochemical c-ErbB-2 product localisation pattern for prognosis in human breast cancer.Detection and temporal appearance of multiple copies of c-erb-B2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction.c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival.Purification and characterization of a new 85-kDa glycoprotein antigen from human breast tumor.p34cdc2 in invasive breast cancer: relationship to DNA content, Ki67 index and c-erbB-2 expression.Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells.Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy.
P2860
Q28284451-D61270F6-DE5B-4705-983D-7AD83A82F816Q33531526-B6224259-9044-489F-8CD8-34E1013CEB93Q35269163-6B90EF00-09D7-4957-8A10-37C7AEEA92F3Q35366750-528C63AB-AFD9-4B10-86AB-49156EF159D4Q35367235-1C667C7F-0A44-44CB-8C40-57B608AB57A5Q35976044-43063F30-738A-4F89-A68B-C7E87751A545Q35976545-453AD837-A86E-49BC-A435-F3525AE3A1C2Q35992905-4663E319-C4B9-427F-9FCD-069D0812C56AQ35993921-F555556B-F1FF-4168-8399-F396D8E65E81Q35994633-6EE58794-D963-4CF3-8943-C611511756C3Q36079541-DB1A7576-D8A0-4FAE-A64D-A2247CD8A03AQ36080795-B5F6AA5F-DB85-4576-94D4-A09CC31A2756Q36081172-0872F20D-5CE4-4A30-B41B-65CB01289700Q36261607-A5899D99-A5CE-4B4F-9E47-80B6D57C0837Q36286928-10380A42-1925-42F4-8AF5-306CDBF1E1C7Q36673825-C8123FF6-4D09-40FA-85E9-FA9F8C395B6AQ37235024-89BF5897-73DB-4231-BDCC-C02E2970DF0AQ37407136-8C822F34-785F-4C1F-91F6-9AF3AE9EC933Q37468213-236CE0A8-B2AC-4EE6-93B5-8AAD424CDE18Q38478519-B3492F43-75A1-4FB7-947A-DBC3D1747238Q38479133-5D5CF1B5-D1E6-4C0F-A997-70E0FD235BFEQ40623955-17C84B57-BCD2-423D-83AB-9F8BD760C78DQ40759266-3D2FFD1B-F1F9-4754-83F7-C56AEC9BFD5FQ40800342-9CCAECA1-14B6-44DE-B43C-3AB55644AEDEQ40942364-357E7729-BD2A-4DCB-9AAB-D4B56640FFBDQ40959643-70CC0522-B8FF-49E6-8256-09452226B962Q41354221-FC9309C1-E5C0-4C43-BD35-D82226EB7487Q41596509-6E9C7843-1C94-4C08-87EB-23B654224CFEQ41637709-74CDC030-1327-43E3-AF92-EEAAB8CFD2AEQ42477146-D7342CCF-D062-46E8-B841-0AA886F78FABQ42590519-49B3A275-124F-4497-81AD-9A6AABAF3AB8Q42807740-2A4C0370-F845-4062-80FC-B4448CB893CDQ43759908-A5615032-A269-4EC1-8AF0-BD2D5EA0A741Q43787651-7CDF9C57-3D37-45B5-A959-A5FD7E737937Q43864539-16F49591-030D-4960-A3BE-9E950882D5E2Q43926200-1B322241-F10E-4C90-BB29-FC11F134FA81Q44071583-C8E2FF4B-181E-4566-8832-710754DA29D4Q44840763-5BB59CD7-DE7B-4DC1-89FC-9E79BB0DA18CQ45865606-F4D2D60C-232A-4513-BBDB-2B3EFAC7E6C5Q52207131-BC855916-2FCB-4A47-A354-3FF40542B7A0
P2860
c-erbB-2 oncogene as a prognostic marker in breast cancer.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
c-erbB-2 oncogene as a prognostic marker in breast cancer.
@en
c-erbB-2 oncogene as a prognostic marker in breast cancer.
@nl
type
label
c-erbB-2 oncogene as a prognostic marker in breast cancer.
@en
c-erbB-2 oncogene as a prognostic marker in breast cancer.
@nl
prefLabel
c-erbB-2 oncogene as a prognostic marker in breast cancer.
@en
c-erbB-2 oncogene as a prognostic marker in breast cancer.
@nl
P2860
P31
P921
P356
P1476
c-erbB-2 oncogene as a prognostic marker in breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1991.78
P407
P577
1991-03-01T00:00:00Z
P5875
P6179
1002926259